Drug absorption in bariatric surgery patients: A narrative review

被引:13
作者
Alalwan, Abdullah Abdulaziz [1 ,2 ]
Friedman, Jeffrey [3 ]
Alfayez, Osamah [1 ]
Hartzema, Abraham [2 ]
机构
[1] Qassim Univ, Coll Pharm, Dept Pharm Practice, Qasim, Saudi Arabia
[2] Univ Florida, Coll Pharm, Pharmaceut Outcomes & Policy, Gainesville, FL USA
[3] Univ Florida, Dept Surg, UF Hlth Bariatr Surg Ctr, Gainesville, FL USA
关键词
bariatric surgery; drug absorption; drug use; pharmacotherapy; therapeutics; Y GASTRIC BYPASS; MORBIDLY OBESE-PATIENTS; SYSTEMIC EXPOSURE; BILIOPANCREATIC DIVERSION; ORAL BIOAVAILABILITY; PRACTICE GUIDELINES; JEJUNOILEAL BYPASS; SLEEVE GASTRECTOMY; PHARMACOKINETICS; MALABSORPTION;
D O I
10.1002/hsr2.605
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Despite the increase in the number of bariatric surgeries performed, little is known about the impact of the surgery on drug absorption. Unpredictability is assumed with drugs, given the anatomical changes after surgery. Objective To evaluate the impact of bariatric surgery on drug absorption based on the type of procedure performed. Methods We conducted a comprehensive literature review searching PubMed/Medline for published studies (from inception to December 2017) that evaluate the use of drugs and the assessment of drug absorption after bariatric surgery. Pharmacokinetic/pharmacodynamic studies, case reports, and observational studies were included in our review. Results We found 60 studies addressing drug use after bariatric surgery. Twenty-eight studies reported a decrease in drug absorption after bariatric surgery while only four studies showed an increase in drug absorption. Unchanged absorption of drugs was seen in 23 studies after the surgery. Conclusion The available information shows variations in drug absorption after bariatric surgery. The unpredictability may result from factors related to the patient, drug, and/or type of surgery. Therefore, pharmacists' involvement and close monitoring of patients after bariatric surgery could be effective to avoid sub-/supratherapeutic responses.
引用
收藏
页数:8
相关论文
共 56 条
[1]  
Abeles Deborah, 2008, Aesthet Surg J, V28, P79, DOI 10.1016/j.asj.2007.09.007
[2]   Laparoscopic gastric banding after heart transplantation [J].
Ablassmaier, B ;
Klaua, S ;
Jacobi, CA ;
Müller, JM .
OBESITY SURGERY, 2002, 12 (03) :412-415
[3]  
Adami, 1991, Obes Surg, V1, P293
[4]   US national trends in bariatric surgery: A decade of study [J].
Alalwan, A. Abdullah ;
Friedman, Jeffrey ;
Park, Haesuk ;
Segal, Richard ;
Brumback, A. Babette ;
Hartzema, G. Abraham .
SURGERY, 2021, 170 (01) :13-17
[5]  
ANDERSEN AN, 1982, INT J OBESITY, V6, P91
[6]   Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass [J].
Azran, Carmil ;
Langguth, Peter ;
Dahan, Arik .
SURGERY FOR OBESITY AND RELATED DISEASES, 2017, 13 (07) :1245-1247
[7]   Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations [J].
Azran, Carmil ;
Wolk, Omri ;
Zur, Moran ;
Fine-Shamir, Noa ;
Shaked, Gad ;
Czeiger, David ;
Sebbag, Gilbert ;
Kister, Olga ;
Langguth, Peter ;
Dahan, Arik .
OBESITY REVIEWS, 2016, 17 (11) :1050-1066
[8]   MALABSORPTION OF HYDROCHLOROTHIAZIDE FOLLOWING INTESTINAL SHUNT SURGERY [J].
BACKMAN, L ;
BEERMAN, B ;
GROSCHINSKYGRIND, M ;
HALLBERG, D .
CLINICAL PHARMACOKINETICS, 1979, 4 (01) :63-68
[9]   The Pharmacokinetics of the CYP3A Substrate Midazolam in Morbidly Obese Patients Before and One Year After Bariatric Surgery [J].
Brill, Margreke J. ;
van Rongen, Anne ;
van Dongen, Eric P. ;
van Ramshorst, Bert ;
Hazebroek, Eric J. ;
Darwich, Adam S. ;
Rostami-Hodjegan, Amin ;
Knibbe, Catherijne A. .
PHARMACEUTICAL RESEARCH, 2015, 32 (12) :3927-3936
[10]   Proximal Roux-en-Y Gastric Bypass Alters Drug Absorption Pattern But Not Systemic Exposure of CYP3A4 and P-glycoprotein Substrates [J].
Chan, Lingtak-Neander ;
Lin, Yvonne S. ;
Tay-Sontheimer, Jessica C. ;
Trawick, Dorothy ;
Oelschlager, Brant K. ;
Flum, David R. ;
Patton, Kristen K. ;
Shen, Danny D. ;
Horn, John R. .
PHARMACOTHERAPY, 2015, 35 (04) :361-369